ArticlePharmaceutics2024

New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs.

Thalia Delgado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.